AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
SOURCE: Journal of Infection, May 1993;26(3):257-264.
Sputum induction and fluorescent antibody testing (FAT) are cost-effective means of diagnosing Pneumocystis carinii pneumonia (PCP) in a patient population of injecting drug users, British researchers report.
Injection drug users experience significant morbidity not only from PCP but from bacterial chest infections (BCI) as well. A previous study (Willocks et al. J Infect, 1992;24:37-42) found that, in such a patient population, 27 percent of respiratory disorders consisted of PCP, while 54 percent turned out to be BCIs. It is difficult to distinguish BCIs from PCP in drug users, but, in many …